Prospect Capital Corporation 6.25% Notes due 2028

(NYSE:PBY) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food.

Contact Information

Website: www.precisionbiosciences.com
Email: IR@precisionbiosciences.com
Main Phone: +1 919 314-5512
Address: 302 East Pettigrew Street
Address 2: Dibrell Building, Suite A-100
State: NC
City / Town: Durham
Country: US
Postal Code: 27701

Issuer Information

Exchange: NYE
CEO: Matthew Kane
Employees: 231
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A